Introduction {#sec1-1}
============

Candidiasis is an important and common disease of the oral mucosa, caused by various *Candida* species \[[@ref1]\], \[[@ref2]\]. *Candida* *albicans* is a major species of pathogens that exist in the form of commensal in the human mouth. The importance of non-albicans such as *Candida glabrata* has increased in recent years \[[@ref3]\]. *Candida glabrata* species is known as the most common cause of infection after *Candida albicans* which is seen in about 31-55% of healthy people. These microorganisms can become pathogens with weakening the immune system \[[@ref4]\], \[[@ref5]\].

Cinnamon zeylanicum blume has been used as an aromatic herb for a long time in the Asian and European herbal medicine for food and medicine application. This herb has been used in traditional medicine for treatment of respiratory, digestive and genital tract defects \[[@ref6]\]. The majority of cinnamon essential oil is cinnamaldehyde \[[@ref7]\]. Various studies have been done on cinnamon properties \[[@ref8]\], \[[@ref9]\], \[[@ref10]\]. They considered cinnamon as an antioxidant, anti-inflammatory, anti-bacterial, anti-diabetes, anticancer and lipid-lowering agent. The standard topical drug to resolve *candida* infection is nystatin mouthwash. However the inappropriate taste of nystatin mouthwash and repeated preparation and use of it during the day leads to dissatisfaction of the patients. Hence the presence of mouthwashes with proper flavour, easier use, and proper effect seems necessary \[[@ref11]\].

Few reports showed the positive effects of cinnamon on the treatment of *Candida albicans* \[[@ref8]\], \[[@ref9]\], \[[@ref10]\] and *Candida glabrata* \[[@ref9]\], and limited studies have investigated its comparative effects with nystatin therapy \[[@ref8]\], \[[@ref12]\]. Providing such herbal medicines that have antimicrobial effects can be useful in reducing side effects and toxic effects on the tissue, as well as economically viable \[[@ref13]\], \[[@ref14]\], \[[@ref15]\].

The purpose of the present study was to evaluate the effects of Cinnamaldehyde (cinnamon derivatives) and Nystatin on *Candida albicans* and *Candida glabrata*. Furthermore, we compared the antifungal effects of Cinnamaldehyde and Nystatin relative to each other using an experimental laboratory intervention method.

Material and Methods {#sec1-2}
====================

An experimental laboratory intervention was designed at the Institute of Biology and Poisoning, School of Medicine, Baqiyatallah University of Medical Sciences. The studied samples included standard species (ATCC) *Candida albicans* (ATCC 90028) and *Candida glabrata*, both of which were obtained from the Mycology Laboratory of the School of Veterinary Medicine, University of Tehran. The present study was carried out using pure cinnamaldehyde (purchased from Merck Germany) and nystatin (purchased from Sigma).

To determine the lowest inhibitory concentration of cinnamaldehyde extract on two strains *Candida albicans* and *Candida glabrata*, we used eight different concentrations. For each microorganism, a plate was used to evaluate the effect of cinnamaldehyde extract, and overall two plates for two types of *candida* were considered. To prepare the required dilutions for nystatin, according to the protocol of the Sigma factory, 1.024 mg of nystatin powder were added to 1 ml of 5% Dimethyl sulfoxide (DMSO) and a concentration of 1.024 mg/ml of nystatin obtained. The culture media were prepared according to the manufacturer's instructions. Then, the *candidates* prepared on the culture medium with sterile inoculating loops and the plate was incubated for 24 hours in a 37°C incubator, and then candida colonies appeared on the culture medium. Fungal suspensions were prepared according to the turbidity McFarland criterion 0.5. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of cinnamaldehyde extract were determined by dilution in the tube. To determine the MIC for a series of eight tubes, we tested the dilutions of each extract. Also, a tube as a positive control containing diluted extract and a negative control medium containing microbial suspension and culture medium was considered. A total of eight dilution series of cinnamaldehyde extract was prepared as 187.5, 125, 93.75, 62.5, 46.8, 31.2, 23.4, 15.6 μl/ml. According to the microdilution method contained in CLSI, in each of the eight microplates, these concentrations, plus 10 μl of fungal suspension were placed. They were incubated 24 hours at 37°C and eventually the first transparent well that indicated the lack of microorganism growth was considered as MIC. The contents of wells without growth were cultured in a solid culture medium, and after 24 hours of incubation, the lowest concentration in which growth was not observed was considered as MFC. To control the test, positive control and negative control were considered, so that we used the culture medium and *candida* for positive control and the culture medium and cinnamaldehyde for negative control. Ethics committee approval was not required for this study.

Regarding the fact that in this type of microbiological experiment, the trials are repeated three times, in the present study, for each *candida* in each concentration, three replications were repeated. The results of the study were reported descriptively in different groups of intervention and control.

Results {#sec1-3}
=======

To detect the antifungal effects of cinnamaldehyde extract and nystatin on the growth of two species of *Candida albicans* and *Candida glabrata*, we used the microdilution method to determine MIC and MFC with three replications.

This method was also used to determine the MIC and MFC of nystatin. The results of MIC and MFC for cinnamaldehyde and nystatin are presented in [Table 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, and [3](#T3){ref-type="table"}.

###### 

Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of Cinnamaldehyde Extract on Candida albicans and Candida glabrata growth

  Row   Concentrations of cinnamaldehyde extract(µg/ml)   Candida albicans   Candida glabrata        
  ----- ------------------------------------------------- ------------------ ------------------ ---- ----
  1     187/5                                             \-                 \-                 \-   \-
  2     125                                               \-                 \-                 \-   \-
  3     93/75                                             \+                 \-                 \-   \-
  4     62/5                                              \+                 \+                 \+   \-
  5     46/8                                              \+                 \+                 \+   \+
  6     31/2                                              \+                 \+                 \+   \+
  7     23/4                                              \+                 \+                 \+   \+
  8     15/6                                              \+                 \+                 \+   \+

###### 

Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of Nystatin on Candida albicans

  Fungi              Sample (oil)   Nystatin         
  ------------------ -------------- ---------- ----- ---
  Candida albicans   62.5           93.7       0.5   1
  ATCC 90028                                         

###### 

Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of Nystatin on Candida glabrata

  Fungi              Sample (oil)   Nystatin       
  ------------------ -------------- ---------- --- ---
  Candida glabrata   48.8           62.5       4   8
  ATCC                                             

This experiment was repeated three times. We also compared the MIC and MFC of cinnamaldehyde and nystatin on the growth of *Candida albicans* and *Candida glabrata* ([Figure 1](#F1){ref-type="fig"}).

![Comparison of minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of Cinnamaldehyde extract and Nystatin on Candida albicans and Candida glabrata](OAMJMS-7-1067-g001){#F1}

The results indicated that nystatin, with a much lower concentration than cinnamaldehyde extract, exerts a lethal effect on *Candida albicans* and *Candida glabrata*.

Discussion {#sec1-4}
==========

Topical treatment for oral candidiasis is nystatin mouthwash, which its requirement to frequent use and unpleasant taste, often leads to patients' dissatisfaction and sometimes lack of continuity of treatment. For this reason, offering a proper flavour mouthwash with the ease of use and proper efficacy seems necessary and practical \[[@ref16]\]. Studies conducted in the last decade clearly show the unpleasant effects of chemical drugs alongside their beneficial effects. Recent studies have paid more attention to the use of medicinal plants due to increased drug resistance to new chemical drugs. This study aimed to evaluate the antifungal effects of cinnamaldehyde extract against *Candida albicans* and *Candida glabrata*, and compare it with the antifungal effect of nystatin. Most previous studies have been conducted on specific pathogens that affect the skin, respiratory, digestive and urogenital system, and few studies have been done on oral mucosal pathogens \[[@ref17]\], \[[@ref18]\], \[[@ref19]\]. For many years, *Candida glabrata* was considered a relatively non-pathogenic saprophytic flora of normal people, unconnected with a serious infection in humans. However, following the large and widespread use of immunosuppressive agents, along with treatment with broad-spectrum antibiotics, the number of systemic and mucosal infections caused by *Candida glabrata* has increased dramatically \[[@ref20]\]. In Fani and Kohanteb (2011) \[[@ref9]\], the antifungal effects of cinnamon on *Candida albicans* are mentioned. Also, Casrto and Lima (2013) pointed to the antifungal effects of essential oil of cinnamon, which the main component of it is eugenol, on *Candida albicans*, *Candida tropicalis*, and *Candida krusei*. They found the direct effect of cinnamon essential oil on the cell wall synthesis of the yeast \[[@ref21]\]. Many researchers have indicated that there is a correlation between the chemical composition and the antifungal activity. They also showed that the strong antifungal activity of the oils derived from the skin and the cinnamon leaf was due to the high levels of cinnamaldehyde (44.2%) and eugenol (90.2%) \[[@ref22]\]. However, other compounds may also contribute to antifungal activity. The study of Arbabi et al., (2011) aimed at comparing the effect of thyme, cloves and cinnamon extract with nystatin on the inhibition of *Candida albicans*. The diameter of the inhibition zone of each plant extract was compared with the diameter of the positive control growth zone with ANOVA. Candida inhibition in the nystatin group was 32.6 ± 0.84, and in cinnamon, extract group was 31.3 ± 0.82. In addition, *candida* inhibition in clove extract group was 27.4 ± 0.82 and finally in thyme evaluated 13 ± 0.82. As a result, the highest effect was first on nystatin, cinnamon, cloves and ultimately thyme (P \< 0.000). The final result was that thyme, cloves, and cinnamon had antifungal effects on the *Candida albicans* \[[@ref12]\]. However, in these two studies, the method of measuring the inhibitory effect of cinnamon extract is not the same, but both studies have confirmed that cinnamon has antifungal effects. The aim of the study of Ataei et al., (2007) was an experimental evaluation on the antifungal effects of absinthium Artemisia, eucalyptus, onion, cinnamon, turmeric, sage, mint, and Calendula officinalis on a standard strain of *Candida albicans* compared to nystatin mouthwash. The results showed that the extract of each of the six herbs had an antifungal effect. Cinnamon has been shown to be more potent and more effective than the onion, mint, Calendula officinalis and sage, with the same effect as turmeric, absinthium Artemisia and eucalyptus. Also, cinnamon, absinthium Artemisia, eucalyptus exhibited significant antifungal effects in comparison with nystatin \[[@ref8]\]. Carvalhinho et al.,)2012) and Condò et al., (2018) also showed a significant activity of cinnamon against *Candida albicans* \[[@ref23]\], \[[@ref24]\]. Gucwa et al., (2018) exhibited both fungistatic and fungicidal activity of some plant oils toward *Candida albicans* and *Candida* *glabrata* isolates and the highest activity was demonstrated for cinnamon oil \[[@ref25]\]. The results of these studies confirm the result of the present study and the antifungal properties of cinnamon.

In conclusion, although the cinnamaldehyde extract in comparison with nystatin can prevent the growth and loss of *Candida albicans* and *Candida glabrata* with higher concentrations; given the antifungal effects of this plant, it is expected that it could be considered as an effective medicinal plant. Since limited studies have been conducted on cinnamon plants, it is suggested to perform extraction of other active substances and its compounds, molecular studies to understand the mechanisms of action of the ingredients, Invivo tests in the animal model following Invitro tests and cell culture experiments.
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